Company Summary
DOD DOD BIOTECH PUBLIC COMPANY LIMITED
Consumer Products/
mai
CG Report:   
 
  Data as of 15 Aug 2022  
Price (B.) 52 Week High/Low P/E (X) P/BV (X) Paid-up (MB.) Market Cap (MB.) EV (MB.) EBITDA (MB.) EV/EBITDA
5.25 13.20 / 5.05 82.59 1.72 205.00 2,152.50 2,483.68 41.25 15.01
News
Date/Time Subject
10 Aug 2022 21:30   Financial Performance Quarter 2 (F45) (Reviewed)
10 Aug 2022 21:30   Management Discussion and Analysis Quarter 2 Ending 30 Jun 2022
10 Aug 2022 21:26   Financial Statement Quarter 2/2022 (Reviewed)
18 Jul 2022 18:49   Report use of proceeds from initial public offering of ordinary shares
21 Jun 2022 06:30   New shares of DOD to be traded on June 22, 2022
more

Company Profile
Address No. 111 Moo 2 Tha Chin Sub-district, Mueang Samut Sakhon District Samut Sakhon 74000
Telephone 0-3444-6333, 0-3444-6444
Fax 0-3444-0373
URL http://www.dodbiotech.com
  Annual Report 2020
Establish Date 11/02/2011 Listed Date 20/06/2018
IPO Price (Baht) 9.30 @Par0.50 Baht
IPO Financial Advisory
  • ADVISORY PLUS CO., LTD.
  • Par 0.50 Baht
    Last Par Change N/A

    Business
    DOD operates as a manufacturer of dietary supplement products under and customers' brand and its brand "Dai a to"

    Free Float 18 Mar 2022 18 Mar 2021
    % /Shareholders
    61.74% 10,624 59.49% 12,815
    Foreign Shareholders 0.46% (As of 15/08/2022) Foreign Limit 49.00%
    NVDR Shareholders  2.05% (As of 15/08/2022)
    5 Yr Price Performance (Adjusted Price)
    Price Performance (Adjusted Price) Compare to Stock (%) Compare to Sector (%) Compare to Market (%)
    5 Days -4.55 -8.33 -4.93
    20 Days - -8.40 -8.22
    60 Days -9.48 -7.98 -11.46
    120 Days -52.27 -37.45 -49.99
    YTD -53.12 -37.54 -55.66
    P/E (X) 82.59 15.72 52.28
    P/BV (X) 1.72 2.54 3.16
    Turnover Ratio (%) 0.20 1.34 0.42

    Top 10 Major Shareholders(@18 Mar 2022) Share %
    1. นาย ล้ำพันธุ์ พรรธนประเทศ 155,900,000 38.02
    2. นาย ดนุพล ชิลลี่ 19,976,800 4.87
    3. บริษัท Thai NVDR Company Limited 16,106,826 3.93
    4. บริษัท ไทยประกันชีวิต จำกัด (มหาชน) 6,136,800 1.50
    5. นาย พงศ์ภน นันทราทิพย์ 5,582,000 1.36
    6. นาย CHAI MANOPHARS 4,480,000 1.09
    7. MR. NOPARIT PUNTHITRA 4,187,000 1.02
    8. KKP SMALL AND MID CAP EQUITY FUND 3,466,700 0.85
    9. นาย สนิท ดุษฎีโหนด 3,438,800 0.84
    10. น.ส. THANYARAHT CHIDENSEA 3,300,000 0.80

    Management Position
    1. Mrs. APAPORN KOSOLKUL CHAIRMAN OF THE BOARD / INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    2. Mr. THANIN SRISETHI EXECUTIVE CHAIRMAN / CHIEF EXECUTIVE OFFICER / DIRECTOR
    3. Mr. DUSIT CHONGSUTTHANAMANEE VICE CHAIRMAN OF THE BOARD OF DIRECTORS / INDEPENDENT DIRECTOR / CHAIRMAN OF THE AUDIT COMMITTEE
    4. Miss SUWARIN KONTHONG DIRECTOR
    5. Mr. AEKPHUSIT BOONSIRIYOTTHAKUL DIRECTOR
    6. Mr. PONGTEP THITHAPAND INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    Accumulated: Turnover Ratio, Value Trade/Day
    Statistics YTD
    15 Aug 2022
    2021
    30 Dec 2021
    2020
    30 Dec 2020
    Listed share (M.) 410.00  410.00  410.00 
    Market Cap (MB.) 2,152.50  4,592.01  3,608.00 
    Price (B./share) 5.25  11.20  8.80 
    BVPS (B./Share) 3.06  3.01  3.04 
    P/BV (X) 1.72  3.73  2.90 
    P/E (X) 82.59  N/A  19.96 
    Turnover Ratio (%) 74.85  805.86  330.24 
    Value Trade/Day (MB.) 17.09  171.99  46.04 
    Beta 0.69  1.09  1.89 
     
    Rate of Return YTD  2021  2020 
    Price Change (%) -53.12  27.27  20.55 
    Dividend Yield (%) N/A  N/A  3.98 
    Payout Ratio N/A  0.79 
    Dividend Policy Not exceeding 50% of the profits after deducting corporate income tax and reserves in pursuant to the laws (with additional conditions)

    Dividend
    Operation Period Dividend/Share Unit Payment Date Type
    01 Jan 2019 - 31 Dec 2019 0.35 Baht 20 May 2020 Cash
     
    Auditor
    (Effective Until 31/12/2022)
    MISS VISSUTA JARIYATHANAKORN/EY OFFICE LIMITED
    MRS. POONNARD PAOCHAROEN/EY OFFICE LIMITED
    Miss MANEE RATTANABUNNAKIT/EY OFFICE LIMITED
    F/S Year ended 31/12
    Latest Type of Report Unqualified opinion
    Financial Data
    Statement of Financial Position (MB.) 6M/2022 
    (01/01/22 
    -30/06/22) 
    6M/2021 
    (01/01/21 
    -30/06/21) 
    2021 
    (01/01/21 
    -31/12/21) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Cash And Cash Equivalents 44.18 136.50 161.68 143.00 82.42
    A/R Net 450.42 286.74 337.74 280.62 231.72
    Inventories 101.21 168.76 113.46 246.33 114.52
    Current Assets 605.35 593.66 626.00 673.42 440.17
    PP&E Net 926.90 834.73 904.14 863.97 801.24
    Non-Current Assets 1,024.13 1,061.27 1,000.99 1,060.06 1,134.44
    Total Assets 1,629.48 1,654.93 1,626.99 1,733.48 1,574.61
    OD 131.32 83.06 77.00 130.39 93.15
    A/P Net 110.61 227.33 120.59 262.14 134.48
    Current portion of LT 27.09 34.17 28.76 39.58 48.68
    Current Liabilities 302.33 361.03 259.16 468.50 288.71
    Non-Current Liabilities 97.96 100.18 105.54 40.06 47.64
    Total Liabilities 400.29 461.21 364.70 508.55 336.35
    Authorized Capital 307.50 296.11 307.50 296.11 296.11
    Paid-Up Capital 205.00 205.00 205.00 205.00 205.00
    Premium (Discount) on Share Capital 890.58 872.62 890.58 939.87 939.87
    Retained Earnings (Deficit) 138.04 114.70 164.47 50.97 125.09
    Treasury Stock - - - - -
    Shares Of The Company Held By Subsidiaries - - - - -
    Other Components Of Equity - - - - -68.82
     - Surplus (Deficits) - - - - -
    Shareholders' Equity 1,254.12 1,210.54 1,280.55 1,214.06 1,219.36
    Minority Interest -24.93 -16.82 -18.26 10.87 18.91
    more
    Statement of Comprehensive Income (MB.) 6M/2022 
    (01/01/22 
    -30/06/22) 
    6M/2021 
    (01/01/21 
    -30/06/21) 
    2021 
    (01/01/21 
    -31/12/21) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Revenue From Operations 294.49 603.44 1,015.32 1,611.20 789.92
    Other Income 3.70 0.59 3.03 9.39 6.01
    Total Revenues 298.26 604.18 1,018.60 1,620.84 797.50
    Costs 203.56 321.20 580.70 856.82 380.02
    Selling And Administrative Expenses 82.93 57.10 126.84 433.21 329.69
    Total Cost And Expenses 287.42 426.53 746.82 1,429.67 709.71
    EBITDA 41.25 214.59 338.82 253.48 142.26
    Depre. & Amor. 30.42 36.94 67.04 76.57 54.47
    EBIT 10.83 177.66 271.78 176.91 87.79
    Net Profit : Owners Of The Parent -26.43 -2.70 49.79 141.25 86.71
    EPS (B.) -0.06 -0.01 0.12 0.34 0.21
    more
    Statement of Cash Flow (MB.) 6M/2022 
    (01/01/22 
    -30/06/22) 
    6M/2021 
    (01/01/21 
    -30/06/21) 
    2021 
    (01/01/21 
    -31/12/21) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Operating Cash Flow -106.82 95.87 145.00 321.28 -42.77
    Investing Cash Flow -48.58 -53.71 -71.68 -127.38 63.94
    Financing Cash Flow 37.90 -48.67 -54.65 -133.32 -75.56
    Net Cash Flow -117.49 -6.50 18.68 60.58 -54.38
    more
    Annualized: ROE, ROA
    Ratios 6M/2022  6M/2021  2021  2020 
    Current Ratio (X) 2.00 1.64 2.42 1.44
    ROE (%) 2.11 2.92 3.99 11.61
    ROA (%) 6.39 14.72 16.17 10.70
    D/E (X) 0.33 0.39 0.29 0.42
    Total Asset Turnover (X) 0.43 0.86 0.61 0.98
    Gross Profit Margin (%) 30.87 46.77 42.81 46.82
    EBIT Margin (%) 3.63 29.40 26.68 10.91
    Net Profit Margin (%) -11.10 -5.03 1.90 8.22

    Information only PP, PO, XR and XD
    Capital Movement (Last 3 Year)
    Date CA Type Changed paid up share Paid up share Par
    No Information Found

    Growth Rate (%) 6M/2022  6M/2021  2021  2020 
    Sales Growth -51.20 -21.84 -36.98 103.97
    COGs Growth -36.62 -17.55 -32.23 125.47
    Total Revenue Growth -50.63 -22.38 -37.16 103.24
    Total Expense Growth -32.61 -36.35 -47.76 101.44
    Net Profit Growth N/A N/A -64.75 62.90

    Annualized
    Cash Cycle 6M/2022  6M/2021  2021  2020 
    A/R Turnover (Times) 1.92 5.65 3.28 6.29
    Avg. Collection Period (Days) 190.46 64.57 111.15 58.03
    Inventory Turnover (Times) 3.43 3.76 3.23 4.75
    Avg. Inventory Period (Days) 106.40 97.12 113.08 76.86
    A/P Turnover (Times) 2.74 3.26 3.03 4.32
    Avg. Payment Period (Days) 133.19 111.96 120.28 84.48
    Cash Cycle (Days) 163.66 49.72 103.94 50.42


    Trading Sign (Latest)
    Trading Alert Posted Date Lifted Date
    No Information Found

    Market Alert (Latest)
    No Information Found
    more

    Only Preferred Share and Warrants
    Other Securities
    Securities Name DOD-W2, DOD-W2-R

    Remark - Calculated from adjusted price
      - Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
      - The information is quarterly updated within 7 business days after the new financial statement is submitted.
      -
     
    Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.
    Source: www.set.or.th (Copyright © The Stock Exchange of Thailand)
    The materials and information on this site are provided for informative and educational purpose only, and do not constitute or form a part of any advice or recommendation regarding any securities. The Stock Exchange of Thailand has no responsibility for the accuracy, suitability and completeness of any information, materials, statements, figures, reports or opinions provided, and has no responsibility for any losses and damages in any cases. In case you have any inquiries or clarification regarding this summary, please directly contact the listed company who made this summary.